Whitehawk Therapeutics, Inc. · NASDAQ:WHWK
Fan Yu reported a 9.40% stake in Whitehawk Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Fan Yu reported a 9.40% stake in Whitehawk Therapeutics, Inc., 5,679,253 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 5,679,253
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 13 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ABG Management Ltd. | 1.40% | 817,939 |
| Ally Bridge Group (NY) LLC | 1.40% | 817,939 |
| Ally Bridge MedAlpha Master Fund L.P. | 1.40% | 817,939 |
| ABG Innovation Capital Partners III GP Limited | 0% | 0 |
| ABG Innovation Capital Partners III GP, L.P. | 0% | 0 |
| Ally Bridge Group Innovation Capital Partners III, L.P. | 0% | 0 |
| ABG Innovation-SO Limited | 0% | 0 |
| ABG Global Life Science Capital Partners V GP Limited | 8.10% | 4,861,314 |
| ABG Global Life Science Capital Partners V GP, L.P. | 8.10% | 4,861,314 |
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | 8.10% | 4,861,314 |
| ABG-SIV, L.P. | 8.10% | 4,861,314 |
| ABG V-SIV Limited | 8.10% | 4,861,314 |
| Fan Yu | 9.40% | 5,679,253 |
Source
Related
- Whitehawk Therapeutics, Inc.
- Fan Yu
- Whitehawk Therapeutics, Inc. shareholders
- Schedule 13G · Fan Yu · Mar 10, 2025
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Form 4 · Dalal Anupam · Jul 30, 2026
- Form 4 · Dugan Margaret · May 18, 2026
- Form 4 · Ball Bryan · May 18, 2026
- Form 4 · Giacobello Scott M. · May 18, 2026